MSH|^~\&|HIVE|RAX|LIMS|RJZ|20241013103300+0000||OML^O21^OML_O21|156bb6ab-15e7-42f3-a819-ecd16a5b4fbd|T|2.4|||ALPID|1||9737383230^^^NHS^NH||London^Cersei||19731003||||2 Barclay Close^Fetcham^^^SE1 2AAORC|NW|1601716017^RPY-EPI|||||||20230908|||9999999998^Smith^Hazel^^^Dr.^^^SDS|||||||||Royal Marsden^^RPY^^^ODSOBR|1|||M119.5^Multi Target NGS Panel Small^England-GenomicTestDirectory||20230908||||||||||9999999998^Smith^Hazel^^^Dr.^^^SDSNTE|1||Free text for diagnosis/reason for referral, transplant, life status at time of request details/ e.g. malignant tumour - molecular assessment will aid managementDG1|1||363358000^Malignant tumour of lung^SNM3DG1|2||relapse^Relapse^England-ReasonForTestingOBX|1|CE|128462008^Metastatic malignant neoplasm (disorder)^SNM3|||||||||||20230908OBX|2|CE|6574001^Necrosis (morphologic abnormality)^SNM3|||||||||||20230908SPM|1|RA257630||364611000000101^Tissue resection sample^SNM3|||||||||||||20230909110000Z|||Y